Daptomycin, a last-resort antibiotic, binds ribosomal protein S19 in humans.

Michael P GotsbacherSungmin ChoHo Jeong KwonPeter Karuso

Published in: Proteome science (2017)

This study provides, for the first time, a human protein target of daptomycin and identifies RPS19 as a possible anticancer drug target for the development of new pharmacological applications and research.

Keyphrases

endothelial cells
methicillin resistant staphylococcus aureus
amino acid
binding protein
genome wide
emergency department
gene expression
induced pluripotent stem cells
staphylococcus aureus
dna methylation
drug induced